4.7 Review

FOLFOX 4 Combined with Herbal Medicine for Advanced Colorectal Cancer: A Systematic Review

Journal

PHYTOTHERAPY RESEARCH
Volume 28, Issue 7, Pages 976-991

Publisher

WILEY
DOI: 10.1002/ptr.5092

Keywords

colorectal cancer; FOLFOX; herbal medicine; tumor response; quality of life; meta-analysis

Funding

  1. Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Province, China
  2. Australian Postgraduate Award at RMIT University, Australia

Ask authors/readers for more resources

This systematic review evaluates the clinical evidence for the addition of herbal medicines (HMs) to FOLFOX 4 for advanced colorectal cancer (ACRC) in terms of tumor response rate (tRR), survival, quality of life and reduction in adverse events (AEs). Seven electronic databases were searched for randomized controlled trials (RCTs) of FOLFOX4 combined with HMs compared to FOLFOX4 alone. Outcome data for 13 randomized controlled trials were analysed using Review Manager 5.1. Risk of bias for objective outcomes including tumor response and survival was judged as low. Publication bias was not evident. Meta-analyses found the addition of HMs improved tRR (RR 1.25, 95% CI 1.06-1.47, I-2 = 0%), one year survival (RR 1.51, 95% CI 1.19-1.90, I-2 = 0%) and quality of life in terms of Karnofsky Performance Status (KPS) gained (RR 1.84, 95% CI 1.54-2.19, I-2 = 0%); alleviated grade 3 and 4 chemotherapy-related AEs for neutropenia (RR 0.33, 95% CI 0.18-0.60, I-2 = 0%), nausea and vomiting (RR 0.34, 95% CI 0.17-0.67, I-2 = 0%) and neurotoxicity (RR 0.39, 95% CI 0.15-1.00, I-2 = 0%), compared to FOLFOX4 alone. The most frequently used herbs were Astragalus membranaceus, Panax ginseng, Atractylodes macrocephala, Poria cocos, Coix lachryma-jobi and Sophora flavescens. In experimental studies, each of these herbs has shown actions that could have contributed to improved tumor response. Copyright (C) 2013 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Health Care Sciences & Services

Electroacupuncture for Poststroke Spasticity: Results of a Pilot Pragmatic Randomized Controlled Trial

Yiyi Cai, Claire Shuiqing Zhang, Anthony Lin Zhang, Cliff Da Costa, Charlie Changli Xue, Zehuai Wen

Summary: This preliminary study on electroacupuncture for poststroke spasticity found no significant difference in outcomes between the intervention group and control group in terms of MAS, Fugl-Meyer Assessment, or Barthel Index. Longer treatment and follow-up periods are recommended for future full-scale trials to evaluate the effectiveness and safety of EA more accurately.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2021)

Letter Obstetrics & Gynecology

Authors' reply re: Acupuncture for recurrent urinary tract infection in women: A systematic review and meta-analysis

Xindong Qin, Meaghan E. Coyle, Anthony L. Zhang, Lihong Yang, Charlie C. L. Xue, Xusheng Liu

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Integrative & Complementary Medicine

Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial

Yihan He, Haibo Zhang, Yifang Li, Shunqin Long, Shujing Xiao, Brian H. May, Anthony Lin Zhang, Xinfeng Guo, Charlie Changli Xue, Chuanjian Lu

Summary: The study found that acupuncture as an adjunctive therapy for cancer pain was effective in reducing pain intensity and daily opioid consumption. Patients in the acupuncture group had a higher proportion of experiencing pain relief compared to the control group. No serious adverse events were reported during the treatment. Further evaluation of the clinical effects of acupuncture as an adjunctive therapy is needed.

ACUPUNCTURE IN MEDICINE (2022)

Review Integrative & Complementary Medicine

Acupuncture for cancer pain: an evidence-based clinical practice guideline

Long Ge, Qi Wang, Yihan He, Darong Wu, Qi Zhou, Nenggui Xu, Kehu Yang, Yaolong Chen, Anthony Lin Zhang, Haiqing Hua, Jinchang Huang, Ka-Kit Hui, Fanrong Liang, Linpeng Wang, Bin Xu, Yufei Yang, Weimin Zhang, Baixiao Zhao, Bing Zhu, Xinfeng Guo, Charlie Changli Xue, Haibo Zhang, Charlie Changli Xue, Charlie Changli Xue, Haibo Zhang, Xinfeng Guo, Darong Wu, Kehu Yang, Yaolong Chen, Long Ge, Runsen He, Haiqing Hua, Jinchang Huang, Ka-Kit Hui, Fanrong Liang, Zuodi Pan, Linpeng Wang, Bin Xu, Nenggui Xu, Yufei Yang, Anthony Lin Zhang, Weimin Zhang, Baixiao Zhao, Bing Zhu, Qi Wang, Yihan He, Qi Zhou, Lihong Yang, Shaonan Liu, Jieyun Li, Liangying Hou, Qian Zhang, Honghao Lai, Xueling Chen, Xueyi Deng, Fuqin Kang

Summary: This study aims to develop an evidence-based clinical practice guideline for acupuncture in the treatment of patients with moderate and severe cancer pain. The guideline proposed three recommendations, providing guidance for the management of cancer pain patients.

CHINESE MEDICINE (2022)

Article Multidisciplinary Sciences

Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study

Shaohua Lyu, Claire Shuiqing Zhang, Anthony Lin Zhang, Jingbo Sun, Charlie Changli Xue, Xinfeng Guo

Summary: This real-world observational study aims to gather practice-based evidence of effects and safety of Chinese herbal medicine (CHM) for migraine, exploring factors related to clinical outcomes. The study will provide comprehensive evidence of CHM for migraine in the context of evidence-based practice and integrate Chinese medicine diagnostic procedures, patients' preferences, and matters relevant to clinical decision making.

PLOS ONE (2022)

Article Integrative & Complementary Medicine

Health professionals' attitudes towards acupuncture/acupressure for post-operative nausea and vomiting: a survey and implications for implementation

Zhen Zheng, Wanda S. Stelmach, Jason Ma, Juris Briedis, Raphael Hau, Mark Tacey, Jeannette Atme, Debra Bourne, Julie Crabbe, Catherine Fletcher, Paul Howat, Jenny Layton, Charlie C. Xue

Summary: This study surveyed healthcare professionals' attitudes towards acupuncture/acupressure and barriers to implementation. The results showed that despite considering it non-mainstream, hospital-based healthcare professionals strongly supported the evidence-based use of acupuncture/acupressure and expressed a desire to learn more.

ACUPUNCTURE IN MEDICINE (2023)

Review Endocrinology & Metabolism

Acupuncture Therapies for Individuals with Overweight or Obesity: An Overview of Systematic Reviews

Jiaxin Chen, Johannah L. Shergis, Xinfeng Guo, Anthony Lin Zhang, Hanlin Wang, Chuanjian Lu, Charlie C. Xue, Changcai Xie

Summary: This research updates and synthesizes evidence from systematic reviews on acupuncture therapies for treating overweight and obesity. It found that acupuncture therapies and auricular acupoint stimulation have benefits in reducing body weight and body mass index. However, there is insufficient evidence for the use of catgut embedding therapy and abdominal acupuncture. Larger and more methodologically sound randomized controlled trials are needed to evaluate the effectiveness of acupuncture therapies.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Review Clinical Neurology

Efficacy and Safety of Oral Chinese Herbal Medicine for Migraine: A Systematic Review and Meta-Analyses Using Robust Variance Estimation Model

Shaohua Lyu, Claire Shuiqing Zhang, Xinfeng Guo, Anthony Lin Zhang, Jingbo Sun, Genghang Chen, Charlie Changli Xue, Xiaodong Luo

Summary: Oral Chinese herbal medicine appears to be more effective than placebo in reducing migraine frequency and pain severity. Greater treatment effects were associated with longer treatment duration, and it was well tolerated.

FRONTIERS IN NEUROLOGY (2022)

Article Oncology

Chinese Medicine Syndrome Differentiation for Early Breast Cancer: A Multicenter Prospective Clinical Study

Qianqian Guo, Meaghan E. Coyle, Anthony Lin Zhang, Xiaohong Xue, Weihe Bian, Aili Song, Xiaohong Xie, Ri Hong, Gang Lyu, Lifang Liu, Qianjun Chen, Charlie Changli Xue

Summary: This multicenter clinical study aimed to identify the Chinese medicine (CM) syndromes and clinical signs and symptoms in women with early breast cancer. The study found consistency between cluster analysis results and the most common syndromes recorded in medical records, and identified the unique syndromes for different treatment stages.

FRONTIERS IN ONCOLOGY (2022)

Article Area Studies

Chinese Medicine as Boundary Object(s): Examining TCM's Integration into International Science Through the Case of Australian--Chinese Research Collaboration

Caragh Brosnan, Fran M. Collyer, Karen Willis, Anthony L. Zhang

Summary: Despite being seen as alternative medicine, Traditional Chinese Medicine (TCM) has been assimilated into mainstream scientific knowledge production and legitimation, even being included in the International Classification of Diseases. In Australia, TCM is a designated area of cooperation with China and is researched by mainstream scientists in universities. This study examines the reasons why TCM has transcended scientific skepticism and identifies aspects of TCM that serve as boundary objects, facilitating its acceptance in bioscientific disciplines.

EAST ASIAN SCIENCE TECHNOLOGY AND SOCIETY-AN INTERNATIONAL JOURNAL (2022)

Article Pharmacology & Pharmacy

Natural products for migraine: Data-mining analyses of Chinese Medicine classical literature

Claire Shuiqing Zhang, Shaohua Lyu, Anthony Lin Zhang, Xinfeng Guo, Jingbo Sun, Chuanjian Lu, Xiaodong Luo, Charlie Changli Xue

Summary: This study searches and analyzes traditional Chinese medicine literature to discover clinical management approaches and herbal medicines for migraine treatment. The anti-migraine effects and mechanisms of action of these herbs and formulas are summarized.

FRONTIERS IN PHARMACOLOGY (2022)

Review Multidisciplinary Sciences

Benefits of herbal formulae containing Poria cocos (Fuling) for type 2 diabetes mellitus: A systematic review and meta-analysis

Yuan Ming Di, Lu Sun, Chuanjian Lu, Xin Feng Guo, Xianyu Tang, Anthony Lin Zhang, Guanjie Fan, Charlie Changli Xue

Summary: Evidence from this study supports the use of Fuling formulae combined with hypoglycaemic agents for the treatment of type 2 diabetes mellitus. The combined therapies appear to be well tolerated.

PLOS ONE (2022)

Article Medicine, General & Internal

Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records

Shaohua Lyu, Claire Shuiqing Zhang, Jingbo Sun, Heng Weng, Charlie Changli Xue, Xinfeng Guo, Anthony Lin Zhang

Summary: This retrospective study analyzed electronic medical records of 2023 migraine patients at the Guangdong Provincial Hospital of Chinese Medicine. Chinese herbal medicine was found to be the predominant treatment for migraines at the hospital, and stress was the most common trigger for migraines.

FRONTIERS IN MEDICINE (2022)

Review Multidisciplinary Sciences

Oral Chinese herbal medicine in reducing the recurrence of colorectal adenoma after polypectomy: A protocol for the systematic review and meta-analysis

Yi Cheng, Yuan Ming Di, Anthony Lin Zhang, Beiping Zhang, Charlie Changli Xue

Summary: This review aims to evaluate the effectiveness and safety of oral Chinese herbal medicine in reducing colorectal adenoma recurrence compared to other treatments. It will provide critical information for clinicians and countries to develop clinical guidelines on colorectal adenoma management.

PLOS ONE (2023)

No Data Available